The landscape of rare disease management in the United Kingdom presents a unique set of challenges and opportunities, particularly when considering conditions as complex and debilitating as Aicardi Syndrome, a neurodevelopmental disorder characterized by the triad of agenesis of the corpus callosum, chorioretinal lacunae, and infantile spasms. Understanding the true scope of the market...